High-beta stock produce higher return: Celgene Corporation (CELG)

Adjust Comment Print

Compton Capital Management Inc bought 5,270 shares as the company's stock declined 19.30% with the market. Pensionfund Dsm Netherlands reported 43,100 shares. Eulav Asset Management who had been investing in Celgene Corp for a number of months, seems to be bullish on the $68.39B market cap company. It closed at $0.04 lastly. About 563,089 shares traded.

Celgene Corporation (CELG) has ATR reading of 2.50. It has underperformed by 42.83% the S&P500. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. It also reduced its holding in Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) by 27,000 shares in the quarter, leaving it with 69,000 shares, and cut its stake in Tjx Cos Inc New (NYSE:TJX). They study the diverse factor and after that study issue different rating to concerning stock whether it is time to sell or buy or even hold the stock. Therefore 91% are positive. Fleetcor Technologies had 55 analyst reports since August 6, 2015 according to SRatingsIntel. Virtus Advisers stated it has 0.04% of its portfolio in Celgene Corporation (NASDAQ:CELG). (NYSE:FLT) on Wednesday, February 3 with "Outperform" rating. On Monday, December 7 the stock rating was upgraded by Wells Fargo to "Outperform". Deutsche Bank maintained Brown & Brown, Inc. Analysts have predicted that CELG will grow it's earning at a 19.65% annual rate in the next 5 years. The stock of General Electric Company (NYSE:GE) has "Hold" rating given on Monday, June 12 by Cowen & Co.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26. The company was maintained on Tuesday, August 22 by Cantor Fitzgerald. Celgene now has an average rating of Hold and a consensus price target of $126.95. The company was initiated on Thursday, January 7 by Suntrust Robinson. The firm has a market cap of $67,500.23, a P/E ratio of 13.07, a PEG ratio of 0.60 and a beta of 1.49.

Celgene Corp (CELG) investors sentiment decreased to 0.83 in 2017 Q4. Its up 0.03, from 0.7 in 2017Q3. Brave Asset stated it has 39,416 shares or 2.14% of all its holdings.

Aviva PLC raised its stake in Celgene Co. Mark Sheptoff Finance Planning Limited Liability Com holds 159 shs or 0.01% of its capital. Pggm Investments has 343,679 shares for 0.2% of their portfolio. This information may indicate the potential future range of the stock and how volatile the shares are. Edgewood Management LLC now owns 10,556,896 shares of the biopharmaceutical company's stock worth $1,539,407,000 after purchasing an additional 98,943 shares during the period. Tealwood Asset invested in 14,405 shs. Mackenzie, Ontario - Canada-based fund reported 78,470 shares. 104,671 were accumulated by Bnp Paribas Arbitrage Sa. Private Ocean Ltd owns 322 shares for 0.02% of their portfolio. First Fincl In reported 463 shares or 0.03% of all its holdings. (NYSE:BRO). Barclays Public Ltd has invested 0% in Brown & Brown, Inc. Wedgewood Partners Inc. owned about 0.13% of Celgene worth $100,427,000 at the end of the most recent reporting period. (NYSE:BRO) for 400 shares.

Celgene Corporation has a consensus outperform rating from 30 Wall Street analysts, and the number of shares now sold short amount to at least 2.23% of shares outstanding. Therefore 63% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. On Wednesday, February 28 the firm has "Buy" rating given by Stifel Nicolaus. Oppenheimer set a $166.00 price target on Celgene and gave the company a "buy" rating in a research note on Friday, December 22nd. On Friday, October 27 the stock rating was maintained by Canaccord Genuity with "Buy". The rating was downgraded by Bank of America to "Neutral" on Tuesday, April 5. Cann reissued a "buy" rating and issued a $163.00 target price on shares of Celgene in a research report on Thursday, February 15th. The company was maintained on Monday, October 30 by Credit Suisse. Four research analysts have rated the stock with a sell rating, twelve have assigned a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company's stock. The firm has "Buy" rating by SunTrust given on Thursday, January 7. JMP Securities maintained Celgene Corporation (NASDAQ:CELG) rating on Friday, July 24. The company was maintained on Friday, May 26 by Jefferies.

Bristol John W & Company Inc, which manages about $6.27 billion and $3.53B US Long portfolio, decreased its stake in Paccar Inc (NASDAQ:PCAR) by 147,444 shares to 718,193 shares, valued at $51.05M in 2017Q4, according to the filing. Also, the number of active investment managers holding Celgene Corp in top ten positions decreased from 119 to 38 for a decrease of 81. American Beacon Advisors Inc. acquired a new position in shares of Celgene during the fourth quarter valued at $120,000.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.19, from 0.69 in 2017Q3. It dropped, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds took stakes and 411 increased stakes. The institutional investor held 357,600 shares of the company at the end of 2017Q4, valued at $1.87 million, up from 201,900 at the end of the previous reported quarter. Bridgewater Assoc Limited Partnership has 290,776 shares. Moody Bancshares Division has 8,000 shares. State Of New Jersey Common Pension Fund D holds 0.2% or 500,000 shares in its portfolio. Bogle Mngmt Lp De has 109,195 shares for 0.84% of their portfolio. 406,177 were reported by Victory Management Inc. 1,062 are held by Oakworth Capital. Howland Capital Management LLC lifted its stake in shares of Celgene by 8.6% in the 3rd quarter. Fiduciary Financial Of The Southwest Inc Tx owns 0.11% invested in Celgene Corporation (NASDAQ:CELG) for 3,635 shares. Guggenheim Capital Limited accumulated 3.70 million shares. Missouri-based First Allied Advisory has invested 0.32% in Celgene Corporation (NASDAQ:CELG).

On Friday, Celgene Corporation (CELG) made the way into the market negative movers list with falling -0.38%. Hightower Advsr Ltd Com holds 0.24% in Celgene Corporation (NASDAQ:CELG) or 275,752 shares.